Mundipharma Industry Breakfast Symposium 

Speakers: Dr Brian Muller (Medical Affairs Director of Mundipharma) and Professor Nicholas Lintzeris (University of Sydney, Division of Addiction Medicine)

Date: Saturday 2 March 2019

Session Time: 0730-0830

Venue: Eureka Room 1, Melbourne Convention and Exhibition Centre

Title 1: NYXOID® – A new nasal spray formulation for opioid overdose 

Mundipharma welcomed Therapeutic Goods Administration registration of NYXOID® nasal spray in September 2018. Dr Brian Muller will discuss the availability of the first intranasal naloxone spray in Australia and present on the pharmacokinetic properties of NYXOID® nasal spray for opioid overdose.

Title 2: Take Home Naloxone in different settings: AoD/NSP services, Emergency Departments and Primary health care settings

Prof Lintzeris will present on:
• findings from a recent evaluation of THN in AoD and NSP services in NSW (ORTHN Project),
• a study examining take home naloxone using Nyxoid in ED settings (The ONE Study), and
• the need for the expansion of THN programs into mainstream health services targeting patients prescribed opioid medications in primary care and specialist pain settings.
The discussion will examine implementation of THN programs in different settings.

 

Proudly supported by Mundipharma